# Norepinephrine Prevent Post-induction Hypotension in High-risk Patients

> **NCT06028256** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital of Kunming Medical University** · enrollment: 180 (estimated)

## Conditions studied

- Anesthesia
- Blood Pressure
- Norepinephrine

## Interventions

- **DRUG:** Norepinephrine Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06028256
- **Lead sponsor:** First Affiliated Hospital of Kunming Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06028256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06028256, "Norepinephrine Prevent Post-induction Hypotension in High-risk Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06028256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*